Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord Injury

Inclusion Criteria: * Aged between 16-65 years * Traumatic spinal cord injury at the level of cervical * American Spinal Injury Association Impairment Scale B * 12 months or more post spinal cord injury subject with stable neurological finding after more than 1 month rehabilitation therapy * No signs of contracture * Good physical condition to go through operation * Must be willing and able to participate in study procedures with no mental and verbal problem * Able to consent by patients or legal representatives Exclusion Criteria: * Serum SGOT/SGPT \> 3 X upper limit of normal or Creatinine \> 1.5 X upper limit of normal * Major surgical procedure in the past 3 months * Penetrating injury * Mechanical ventilation * Serious pre-existing medical conditions * Recently diagnosed infection (Urinary tract infection, Pneumonia etc) * Positive skin test for penicillin * Positive result for viral markers (human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and Venereal Disease Research Laboratory (VDRL) test) * Pregnant women, women of childbearing potential who do not want adequate contraception, breastfeeding females * Unwilling to participate in study * Patients with psychiatric disorder severe as to make compliance with the treatment unlike, and signing informed consent impossible * Drug abuse in the past 1 year * Participating in other clinical trials in the past 1 month * Inappropriate patients to participate in the study according to the chief investigator